Tower Research Capital (TRC)’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,936
| Closed | -$3.41K | – | 6293 |
|
|
2023
Q3 | $3.41K | Buy |
7,936
+3,936
| +98% | +$1.69K | ﹤0.01% | 5008 |
|
|
2023
Q2 | $5.08K | Buy |
4,000
+2,962
| +285% | +$3.76K | ﹤0.01% | 4841 |
|
|
2023
Q1 | $1K | Buy |
+1,038
| New | +$1K | ﹤0.01% | 5690 |
|
|
2022
Q4 | – | Sell |
-10,245
| Closed | -$50K | – | 6599 |
|
|
2022
Q3 | $50K | Buy |
10,245
+9,035
| +747% | +$44.1K | ﹤0.01% | 3160 |
|
|
2022
Q2 | $11K | Sell |
1,210
-2,407
| -67% | -$21.9K | ﹤0.01% | 4406 |
|
|
2022
Q1 | $23K | Buy |
3,617
+188
| +5% | +$1.2K | ﹤0.01% | 3417 |
|
|
2021
Q4 | $30K | Buy |
3,429
+515
| +18% | +$4.51K | ﹤0.01% | 3239 |
|
|
2021
Q3 | $35K | Buy |
2,914
+2,048
| +236% | +$24.6K | ﹤0.01% | 3252 |
|
|
2021
Q2 | $8K | Buy |
+866
| New | +$8K | ﹤0.01% | 4522 |
|